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Abstract
This review will focus the roles of TNF-alpha, IL-1 alpha, and IL-1 beta in the mammalian testis and
in two testicular pathologies, testicular torsion and orchitis. TNF alpha in the testis is produced by
round spermatids, pachytene spermatocytes, and testicular macrophages. The type 1 TNF receptor
has been found on Sertoli and Leydig cells and numerous studies suggest a paracrine mode of action
for TNF alpha in the normal testis. IL-1 alpha has been reported to be produced by Sertoli cells,
testicular macrophages, and possibly postmeiotic germ cells. IL-1 receptors have been reported on
Sertoli cells, Leydig cells, testicular macrophages, and germ cells suggesting both autocrine and
paracrine functions. While these proinflammatory cytokines have important roles in normal
testicular homeostasis, an elevation of their expression can lead to testicular dysfunctions.
Testicular torsion is a clinical pathology with results in testicular ischemia and surgical intervention
is often required for reperfusion. A pivotal role for IL-1beta in the pathology of testicular torsion
has been recently described whereby an increase in IL-1beta production after reperfusion of the
testis is correlated with the activation of the stress-related kinase, c-jun N-terminal kinase, and
ultimately resulting in neutrophil recruitment to the testis and germ cell apoptosis. In autoimmune
orchitis, on the other hand, TNF alpha produced by T-lymphocytes and macrophages of the testis
has been implicated in the development and progression of the disease. Thus, both
proinflammatory cytokines, TNF alpha and IL-1, have significant roles in normal testicular functions
as well as in certain testicular pathologies.
Introduction
The mammalian testis is an immunologically privileged
site whereby tight junctions between Sertoli cells typically
segregate germ cell autoantigens within the adluminal
and luminal compartments of the seminiferous tubules
[1]. Proinflammatory cytokines and other immune mod-
ulators must be tightly regulated in order to prevent
inflammatory and immune responses in the testis. This
review will focus on the localization and functional roles
of tumor necrosis factor-α (TNFα) and interleukin-1 (IL-
1) in the mammalian testis and described two pathologi-
cal conditions of the testis where a role for the proinflam-
matory cytokines has been determined.
TNFα is a multifunctional cytokine with effects not only
in the proinflammatory response [2] but in immunoregu-
latory responses [3], and apoptosis [4]. TNFα is produced
in numerous cell types and is initially synthesized as a
transmembrane precursor that undergoes proteolytic
cleavage from the cell surface to a soluble monomer of 17
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kDa [5]. Soluble or secreted TNFα forms biologically
active homotrimers; however, trimerization of TNFα may
also occur with other members of the TNF protein family
forming membrane-anchored heterotrimers that are also
biologically active [6].
Two families of TNFα receptors (TNFR) have been highly
characterized. The TNFR type 1 family includes TNFR1
(p55TNFR; CD120a), Fas (CD95), death receptor (DR)3,
DR4, DR5, and DR6 [7]. The type 1 TNFRs are known for
their ability to induce cell death via an amino acid motif
in their cytoplasmic domains termed the death domain
(DD) [7]. Upon ligand binding to the TNFR1 the intracel-
lular adaptor protein TRADD (TNFR-associated death
domain protein) is recruited to the DD of the receptor.
TRADD can then recruit FADD (Fas-associated death
domain protein) ultimately leading to the activation of
caspases and cell death [7,8]. Alternatively, TRADD
bound to TNFR1 can lead to the recruitment of cIAP (cel-
lular inhibitor of apoptosis) or RIP (receptor interacting
protein) enabling the binding of TRAF-2 (TNFR-associ-
ated factor-2). This complex formation does not result in
apoptosis but rather leads to the activation of the NFκB
pathway and/or the activation of the mitogen-activated
protein kinase (MAPK) c-jun N-terminal kinase (JNK) or
p38 [7]. Thus TNFR1 has dual signaling capabilities for
either cell death or cell survival. Which pathway is selected
appears to be a function of the adaptor proteins.
The TNFR type 2 family includes the TNFR2 (p75TNFR;
CD120b), CD30, CD40, lymphotoxin receptor, RANK,
and BAFF. The intracellular domains of these receptors do
not contain DD but contain domains that associate with
different TRAFs leading to the activation of cell signaling
events [7,8].
The IL-1family of peptides consists of three gene products,
IL-1α, IL-1β, and the IL-1 receptor antagonist (IL-1Ra) [9].
Both IL-1α and IL-1β are secreted by macrophages and
have been termed the 'alarm cytokines'. They are pleio-
tropic cytokines with many well characterized effects on
immune responses [10,11]. Both IL-1α and IL-1β are
known to cause inflammation and induce the expression
of proinflammatory peptides such as inducible nitric
oxide synthase, cyclooxygenase 2, IL-6, and TNFα [10]. In
fact, IL-1α, IL-1β, and TNFα stimulate their own as well as
each other's production in an amplification loop [10,11].
Both IL-1α and IL-1β are initially synthesized as precur-
sors of 31 kDa that get proteolytically processed to their
mature, 17 kDa forms [12]. IL-1α is processed by calpain
while IL-1β is processed by IL-1β-converting enzyme also
know as caspase-1 [12]. IL-1α and IL-1β differ from other
cytokines in that they lack a signal sequence and cannot
pass through the endoplasmic reticulum (ER) and Golgi
apparatus. Their mechanism of secretion is not com-
pletely understood [13]. On the other hand, IL-1Ra does
have a signal sequence and is secreted by the well charac-
terized ER-Golgi pathway [14].
Two receptors have been described, IL-1 type I receptor
(IL-1RI) and IL-1 type II receptor (IL-1RII), both receptors
bind IL-1α and IL-1β and both receptors have reported to
be expressed on many cell types. The IL-1RI is a signaling
receptor. Following ligand binding to the receptor a pro-
tein termed IL-1R acceptor protein is recruited to the com-
plex. This complex then triggers the activation of IL-1
receptor-associated kinase (IRAK) which ultimately leads
to gene activation [15]. On the other hand, IL-1RII is a
non-signaling receptor that has been reported to be a
decoy receptor [16]. Therefore, ligand binding to signal-
ing IL-1 receptor, IL-1RI, may be regulated by the binding
of ligand to IL-1RII or can be blocked by the binding of IL-
1Ra to the IL-1RI. To add yet another level of complexity
both receptors may be released from the cell surface and
bind soluble ligand [17]. Both the IL-1 and TNFα signal-
ing pathways can be stimulated under normal and patho-
logical conditions in the testis.
Testicular torsion is characterized by a twisting of the sper-
matic cord that renders the testis ischemic. Surgical inter-
vention is usually necessary for counter-rotation of the
testis and reperfusion of the tissue [18]. In rodent models
of testicular torsion there is an increase in neutrophils to
the testis that is associated with oxidative stress and germ
cell-specific apoptosis [19-21]. Recent data has demon-
strated an increase in TNFα and IL-1β expression after
reperfusion of the testis and that IL-1β may be responsible
for stimulating a stress-related kinase signaling pathway
leading to neutrophil recruitment from the testicular vas-
culature [22]. Another testicular pathology is autoim-
mune orchitis which occurs in several species. In humans
several idiopathic diseases have been described that are
similar to autoimmune orchitis, and these diseases are
associated with male infertility [23]. In an animal model
system termed experimental autoimmune orchitis (EAO)
TNFα production by testicular T lymphocytes [24] and
macrophages [25] has been linked to progression of the
disease. Understanding the roles of proinflammatory
cytokines in the testis and in testicular pathologies will aid
in the development of therapies to rescue the testis from
the adverse effects of inflammation and will give insights
into male infertility.
Role of TNFα in the normal testis
Localization of TNFα and TNFα receptors in the testis
By enriching for specific germ cell populations using unit
gravity sedimentation and analyzing for the secretion of
bioactive TNFα and for TNFα mRNA De et al [26] have
shown that round spermatids secreted TNFα and bothReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/9
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pachytene spermatocytes and round spermatids con-
tained TNFα mRNA, though at two different transcript
sizes [26]. Results from in situ hybridization studies con-
firmed the presence of TNFα mRNA in the round sperma-
tids and pachytene spermatocytes and detected mRNA in
testicular interstitial macrophages as well [26].
Interstitial testicular macrophages have also been
described a possible a source of TNFα. Early studies by
Hutson [27] on collagenased dispersed rat testicular mac-
rophages found TNFα activity in the conditioned media.
However, later studies from the same investigators, found
that no TNFα was detected in testicular interstitial fluid or
in testicular macrophages isolated without collagenase
[28] suggesting that TNFα is not constitutively expressed
in the normal testis. Treatment of non-collagenase iso-
lated rat testicular macrophages with lipopolysaccharides
(LPS) did induce TNFα secretion indicating that TNFα
may be produced by testicular macrophages under certain
conditions [28].
To determine which cell type TNFα may be acting upon
De et al [26] performed Northern blot analysis for TNFR1
in isolated cell populations and found that Sertoli and
Leydig cells contained the mRNA for TNFR1. Using cul-
tured porcine Sertoli cells Mauduit and coworkers [29]
demonstrated that Sertoli cells bound radiolabeled TNFα
via TNFR1 and that treatment with follicle stimulating
hormone (FSH) upregulated TNFR1. TNFR2 or the p75
TNF receptor was not detected [29].
Taken together results of the above studies suggest that
TNFα is normally produced by germ cells, notably round
spermatids, and that the receptors are on Sertoli and Ley-
dig cells.
Role of TNFα in the seminiferous epithelium
Numerous functional roles for TNFα in the mammalian
have been described by a number of laboratories. In germ
cells TNFα has been reported to increase the expression of
cytochrome P450 aromatase, an enzyme responsible for
the synthesis of estrogen from androgens [30]. The TNFα-
mediated increase in cytochrome P450 aromatase was
found to be predominantly in pachytene spermatocytes,
while an inhibitory effect was observed in round sperma-
tids [30].
TNFα also acts in indirect ways to support spermatogene-
sis. As stated earlier, TNFα can stimulate the activation of
the transcription factor NFκB and, indeed in, cultures of
rat Sertoli cells TNFα stimulated nuclear NFκB binding
[31]. The intracellular androgen receptor (AR) in Sertoli
cells binds and mediates testosterone signaling. Studies by
Delfino et al [32] found that TNFα stimulated binding of
NFκB to the AR promoter and increased endogenous AR
in primary cultures of Sertoli cells.
TNFα has also been shown to suppress Mullerian inhibit-
ing substance (MIS). MIS is essential for normal sex differ-
entiation and its expression is strictly regulated.
Expression of MIS in Sertoli cells is high in the fetal to pre-
pubertal period but then decreases after puberty. Studies
by Hong et al [33] have shown that TNFα is the molecule
responsible for suppression of MIS. Treatment of testis
organ cultures with TNFα caused a decrease in MIS expres-
sion and testis from TNFα knockout mice showed high
and prolonged MIS expression. The suppressive ability of
TNFα on MIS was found to be due to the activation of
NFκB which subsequently associated with and repressed
the transcription factor SF-1 [33].
Transferrin is a major transporter of iron into cells [34]. In
the testis where the blood-testis barrier prevents macro-
molecules and several electrolytes from entering the adlu-
minal compartment iron is transported into the
compartment from the circulatory system by transferrin
produced in Sertoli cells [35]. Early studies showed that
transferrin production is regulated by germ cells [36].
More recently, TNFα was found to increase transferrin
mRNA and protein levels in Sertoli cells in vitro [37]. The
effect of TNFα on Sertoli cell transferrin production was
also found to be dependent on the stage of the cycle of the
seminiferous epithelium with Sertoli cells from stages IX-
XI and XIII most clearly responding [38]. These results
together with those indicating that TNFα is secreted by
germ cells [26] suggest that TNFα produced by germ cells
acts in a paracrine manner to upregulate transferrin pro-
duction by Sertoli cells and thus maintain
spermatogenesis.
TNFα has also been shown to stimulate lactate dehydro-
genase A expression in Sertoli cells [39]. Postmeiotic germ
cells utilize lactate derived from Sertoli cells rather than
glucose as an energy substrate [40]. Lactate dehydrogenase
A is a key enzyme involved in lactate production. Treat-
ment of Sertoli cells with TNFα caused a dose-dependent
increase in lactate dehydrogenase A mRNA expression
[39]. In other studies it was also found that TNFα
increased the activity of lactate dehydrogenase in cultured
Sertoli cells [41]. These results again suggest an important
paracrine mode of action for TNFα on maintaining sper-
matogenesis. Monocarboxylate transporters (MCTs) are
responsible for the transportation of lactate across the
plasma membrane and recent studies have demonstrated
the presence of MCT2 in differentiated murine germ cells
and suggest it may play a role in lactate uptake [42]. Inter-
estingly, TNFα was found to inhibit MCT2 expression.
These results led Boussouar et al [42] to hypothesize that
the inhibitory effect of TNFα on MCT2 in germ cells wasReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/9
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related to the stimulatory effect of TNFα on Sertoli cell lac-
tate production and would prevent an over accumulation
of lactate in the germ cells.
Studies by Pentikainen et al [43] have found that TNFα
inhibited in a concentration dependent manner the germ
cell apoptosis observed in segments of human seminifer-
ous epithelium cultured under serum-free conditions.
TNFα down-regulated Fas ligand (FasL) production by
segments of seminiferous epithelium; thus, Pentikainen et
al [43] suggested that TNFα produced by germ cells works
in a paracrine fashion to down-regulate FasL production
by Sertoli cells and promote germ cell survival. TNFα has
also been reported to increase both membrane-bound
and soluble forms of Fas in cultured Sertoli cells [44]. Ser-
toli cells treated with low concentrations of TNFα secreted
the soluble form of Fas that was capable of inhibiting a
basal level of apoptosis. At higher concentrations of
TNFα, however, upregulation of membrane bound Fas
was predominant and the germ cells were susceptible to
FasL-mediated apoptosis. These results suggest that under
physiologically low concentrations of TNFα the soluble
form of Fas is produced by Sertoli cells and acts as a sur-
vival factor for germ cells; whereas, at high concentrations
TNFα such as during inflammation TNFα induces mem-
brane bound Fas which primes the Sertoli cells for FasL
induced cell death [44].
Another way in which TNFα exerts a paracrine effect on
Sertoli cells is through the stimulation of insulin-like
growth factor binding protein-3 (IGFBP-3) [45]. By
increasing IGFBP-3 levels in treated Sertoli cells TNFα was
able to antagonize the action of IGF-1 on FSH binding to
Sertoli cells [45]. TNFα was able to increase IL-1α and IL-
6 production from cultures of rat Sertoli cells [46]. These
data suggest that TNFα can alter the cytokine secretion
profile of Sertoli cells that may affect Sertoli cell functions
and ultimately spermatogenesis.
Studies investigating the signal transduction pathways
stimulated by TNFα in Sertoli cells have found that treat-
ment of murine Sertoli cells with TNFα resulted in the
activation of JNK as well as p38 MAPK [47]. By employing
a specific p38 inhibitor it was demonstrated that activa-
tion of the p38 MAPK pathway led to the production of
IL-6 by TNFα stimulated Sertoli cells and activation of the
JNK pathway increased surface expression of intercellular
adhesion molecule-1 (ICAM-1) and vascular cell adhe-
sion molecule-1 (VCAM-1) [47]. Since TNFα plays a role
in increasing cell adhesion molecules, De Cesaris et al [47]
suggested that the effect of TNFα on Sertoli cells may be
pathogenic in the outbreak of autoimmune disorders in
the testis.
TNFα has also been shown to effect Sertoli cell tight junc-
tion assembly, collagen α 3(IV) synthesis, and enzymes
and their inhibitors that effect the extracellular matrix
(ECM) [48]. By increasing the expression of matrix metal-
loprotease-9, TNFα has been found to perturb Sertoli cell
tight junction formation; however, TNFα also increased
the inhibitor of metalloprotease-1 and collagen α 3(IV)
production suggesting a feedback mechanism to replenish
the collagen network and reform tight junctions [48].
These results have led Siu et al [48] to suggest that TNFα
influences the dynamics of the Sertoli cell tight junctions
through effects on the ECM.
Glutathione S-transferase-α (GSTα) is an enzyme
expressed by Sertoli cells involved primarily in detoxifica-
tion. TNFα was found to decrease basal as well as hor-
mone-stimulated GSTα in cultures Sertoli cells [49].
Benbrahim-Tallaa et al [49] suggested that increased levels
of TNFα in the testis may alter the detoxification processes
against genotoxic products during spermatogenesis.
TNFα in combination with other cytokines and lipopoly-
saccharides has been shown to stimulate inducible nitric
oxide synthase (iNOS) and nitrite in Sertoli cells as well as
seminiferous pertitubular cells [50]. Similarly treating Ser-
toli cells with a combination of cytokines that included
TNFα, IL-1β, and IL-6 caused a more than additive effect
on transferrin and cGMP secrection [51].
Based on the above studies TNFα has numerous roles in
normal testicular functions (Table 1). At least one study
suggests that the levels of TNFα produced in the testis may
be an important factor. Low levels of TNFα may preferen-
tially regulate normal testicular homeostasis; whereas, ele-
vated levels influence or initiate pathological conditions
in the testis.
Role of TNFα in testicular interstitial cells
Since testicular macrophages may be a source of TNFα
and since testicular macrophages and Leydig cells are inti-
mately associated through membrane digitations a role
for TNFα in Leydig cell steroidogenesis has been investi-
gated. Treatment of isolated murine Leydig cells with
TNFα resulted in a significant decrease in basal testoster-
one secretion as well as cAMP-stimulated testosterone
production [52]. This TNFα inhibitory affect on the
cAMP-stimulated testosterone production in Leydig cells
was found to be due to a decrease in mRNA and protein
levels of two cytochrome P450 enzymes important in tes-
tosterone biosynthesis, cholesterol side-chain cleavage
enzyme and 17α-hydroxylase/C17–20 lyase [52]. Further-
more, Li et al [53] have demonstrated that the inhibitory
affect of TNFα on 17α-hydroxylase/C17–20  lyase gene
expression is mediated via protein kinase C. The inhibi-
tory affect of TNFα on LH/hCG-induced testosteroneReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/9
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secretion has also been reported in porcine Leydig cells
[54]. In these studies the mechanism of the inhibitory
affect of TNFα was reported to be due to a decrease in ster-
oidogenic acute regulatory protein mRNA and protein lev-
els [54]. Results from two independent studies have also
shown that the TNFα inhibitory affects on Leydig cell tes-
tosterone secretion may involve a sphingomyelin/cera-
mide-dependent pathway [55,56]. Thus, results from
numerous laboratories employing mouse, rat, or porcine
Leydig cells have reported an inhibitory affect of TNFα on
testosterone production; however, it remains unclear
whether Leydig cells are normally exposed to TNFα under
normal testicular homeostasis or only after testicular mac-
rophages are activated.
Besides having an affect on Leydig cell testosterone pro-
duction TNFα has also been reported to increase plas-
minogen activator inhibitor-1 (PAI-1) expression in rat
testicular peritubular cells indicating that it may be
involved in controlling protease activity [57]. The authors
suggest, however, that the biological effects of TNFα on
PAI-1 may be secondary to due to epidermal growth factor
receptor (EGFR) signaling since TNFα also increased
EGFR mRNA and EGF binding in the peritubular cells
[57]. Table 1 summarizes the key roles of TNFα in the
mammalian testis.
Role of IL-1 in the normal testis
Localization of IL-1 and IL-1 receptors in the testis
It appears that some controversy exists on the exact cell
type in the mammalian testis that produces IL-1; however,
the procedures used and the age of the animals may
account for some of these differences. Early studies in the
rat identified an IL-1-like factor in the testis that first
appears during puberty, is stage dependent, and is corre-
lated with spermatogonial DNA synthesis [58]. Results of
autoradiographic studies on membrane preparations
from the mouse testis revealed that IL-1α displayed signif-
icantly higher binding then IL-1β and the highest binding
density was observed in the interstitial areas of the testis
[59]. By employing RT-PCR and in situ hybridization
techniques Jonsson et al [60] have demonstrated that the
IL-1-like protein is IL-1α and not IL-1β or IL-6. Extracts of
seminiferous tubule segments also demonstrated the pres-
ence of bioactive IL-1 but not IL-6. Results of the in situ
hybridization studies revealed the IL-1α mRNA was local-
ized to Sertoli cells in animals greater than 20 days of age.
In younger rats no IL-1α transcripts were detected in the
testis. The IL-1α mRNA was present in Sertoli cells at all
stages of the seminiferous epithelium except stage VII
which was negative [60]. Interestingly the presence of IL-
1α in Sertoli cells is dependent upon the presence of germ
cells. In animals depleted of germ cells either by exposure
to radiation prenatally or by treating adults with busulfan
no IL-1α mRNA was detected in Sertoli cells [60]. Studies
by Cudicini et al [61] have demonstrated the presence of
IL-1α in human Sertoli cells but also demonstrated the
presence of IL-1α and IL-1β in isolated Leydig cells.
Rozwadowska et al [62] also demonstrated IL-1α mRNA
expression in seminiferous tubules and IL-1β mRNA
expression in the interstitium of human testis. Further,
Hales et al [63] demonstrated the presence of IL-1 mRNA
in testicular macrophages. In contrast, Haugen et al [64]
reported the presence of IL-1α protein and mRNA in iso-
lated postmeiotic germ cells.
To further complicate matters regarding IL-1 in the testis,
Gustafsson et al [65] reported that three isoforms of IL-1α
Table 1: Summary of the Effects of TNFα on Sertoli, Leydig, and Peritubular Cells
Sertoli Cells Leydig Cells Peritubular Myoid Cells
increase cytochrome decrease testosterone [52-56] increase PAI-1 [57]
P450 aromatase [30]
increase NFκB activity [31]
increase AR [32]
decrease MIS [33]
increase transferrrin [37,38]
increase LDH-A [39,41]
decrease MCT2 [42]
decrease FasL [43]
increase Fas [44]
increase IGFBP-3 [45]
increase IL-6 [46,47]
increase ICAM and VCAM [47]
increase MMP9 [48]
increase TIMP-1 and collagen [48]
decrease GST [49]Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/9
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are produced in the testis that may be posttranslational
modifications of the IL-1α precursor and their differential
effects are unknown. Also the IL-1 receptor antagonist, IL-
1Ra, has been reported to be constitutively produced by
isolated mouse Sertoli cells, but since the molecule was
found intracellularly and no IL-1Ra bioactivity could be
detected in the conditioned media [66] an inhibitory role
may be unlikely.
Both IL-1Rs have been reported in the testes of mouse, rat,
and human. IL-1RI and IL-1RII mRNA were observed in
Sertoli, Leydig, and testicular macrophages from all three
species whereas, only the rodent germ cells expressed IL-
1RI and IL-1RII mRNA [67].
Role of IL-1 in the seminiferous epithelium
IL-1α has been reported to be a potent growth factor for
immature Sertoli cells. Recent studies by Petersen et al
[68] have not only identified the IL-1RI in cultures of Ser-
toli cells from 8 to 9 day rats but also demonstrate that IL-
1α enhances Sertoli cell proliferation. Treatment of Sertoli
cells with a combination of IL-1α and FSH showed a syn-
ergistic affect on proliferation [68]. These results suggest
that IL-1α may serve as a growth factor for Sertoli cells
(Table 2).
Role of IL-1 in testicular interstitial cells
The intimate association of Leydig cells and interstitial
macrophages has prompted several studies investigating
possible immuno-endocrine interactions. Numerous
early studies have reported that IL-1 inhibits basal and
LH/hCG-stimulated testosterone production by Leydig
cells [69-71]. However, other studies have shown that IL-
1β can stimulate testosterone levels in Leydig cells
[72,73]. The apparent discrepancies in the results may
come from differences in the experimental conditions or
methodologies. In cultures of isolated rat Leydig cells
from animals 10 to 20 days old IL-1β caused a dose-
dependent increase in the incorporation of 3H-thymidine
into DNA [74]. IL-1α also had an affect on 3H-thymidine
incorporation; however, it was much less potent than IL-
1β. The effect of IL-1β was not observed in Leydig cell iso-
lated from older animals suggesting that IL-1β may play a
role in the proliferation of Leydig cells during prepubertal
development [74].
Mice that lack a functional IL-1 signaling receptor (IL-1RI)
exhibit normal fertility, have normal serum testosterone,
and normal testicular levels of steroidogenic enzymes sug-
gesting that IL-1 receptor signaling is not required in Ley-
dig cell steroidogenesis [75]. However, in studies where
intratesticular macrophages have been depleted either via
the injection of silica or by genetic mutation the develop-
ment of normally functioning Leydig cells is impaired
[76]. These observations lead Hales [69] to suggest that
during testicular development and under non-inflamma-
tory conditions interstitial macrophages provide the
appropriate microenvironment to support Leydig cells.
Table 2 summarizes the key functional roles of IL-1α and
IL-1β in the mammalian testis.
Proinflammatory cytokines in testicular 
pathology
Testicular torsion
Recent studies from our laboratory have reported an
increase in the proinflammatory cytokines TNFα and IL-
1β after ischemia/reperfusion (IR) of the testis and suggest
a role for the proinflammatory cytokines as early media-
tors of IR-injury in the testis [22]. In the human, ischemia
of the testis can result during a medical condition known
as testicular torsion in which there is twisting of the sper-
matic cord. It is a medical emergency and surgical inter-
vention is usually required for reperfusion of the testis;
however, even after reperfusion testicular atrophy is com-
mon. Early studies from our laboratory have shown that
IR of the rat testis results in a permanent loss of sperma-
togenesis despite the return of blood flow [77] and the
continued presence of functional Leydig [78] and Sertoli
cells [79]. The IR-induced loss of spermatogenesis has
been shown to be the result of germ cell-specific apoptosis
[20,21,80]. Occurring contemporaneously with the IR-
induced germ cell-specific apoptosis is an increase in neu-
trophils [20,21] and reactive oxygen species [19] in the
testis. Germ cell-specific apoptosis after IR of the testis is
dependent upon the recruitment of neutrophils to the tes-
tis [5], and we have recently reported that an increase in
proinflammatory cytokines after IR of the testis is corre-
lated with activation of signaling pathways leading to
neutrophil recruitment [22].
As early as 0.5 hr after IR of the murine testis an increase
in the expression of both TNFα and IL-1β is observed [22]
and this precedes the activation of JNK. JNK is a stress-
related kinase that plays a critical role in the cellular
response to many types of cellular stress. Two transcrip-
tion factors downstream of JNK, ATF-2 and c-jun, are also
activated, and immunolocalization of activated, phos-
phorylated, JNK (phospho-JNK) demonstrated immuno-
Table 2: Summary of the Effects of IL-1 α and IL-1β on Sertoli and 
Leydig Cells
Effects of IL-1α on Sertoli 
Cells
Effects of IL-1β on Leydig 
Cells
increase proliferation [68] decrease testosterone [69-71,74]
increase testosterone [72,73]Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/9
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reactivity in intratesticular blood vessels [22].
Corresponding with this was an increase in E-selectin
mRNA and protein 4 hr after IR of the testis [22]. Indeed,
the E-selectin promoter is known to contain a positive reg-
ulatory domain II site which has been shown to bind a
heterodimer of ATF-2 and c-jun [81]. E-selectin is an
endothelial cell adhesion molecule responsible for the
tethering and slow rolling of neutrophils to endothelial
cells [82]. These results suggest that an increase in TNFα
and/or IL-1β after IR of the testis stimulates the activation
JNK signaling pathway leading to the expression of E-
selectin in endothelial cells and ultimately neutrophil
recruitment (Figure 1). In order to determine if TNFα, IL-
1β, or both proinflammatory cytokines were eliciting this
response, the cytokines were injected either alone or in
combination to the testis and phosphorylation of JNK
and neutrophil recruitment was examined. Results from
these experiments revealed that injection of IL-1β mim-
icked the effects of IR on the testis, causing an activation
of JNK and a recruitment of neutrophils to the testis [22].
Thus, an increase in IL-1β after IR of the testis stimulates
an intracellular signaling cascade in testicular endothelial
cells resulting in neutrophil recruitment and eventually
germ cell death. The cell type responsible for the increase
in IL-1β production after IR of the testis is currently
unknown. Even though TNFα did not have a role in neu-
trophil recruitment or JNK activation in the testis, prelim-
inary experiments in our lab suggest that the increase in
TNFα may lead to the activation of NFκB in Sertoli cells
(Lysiak and Turner, unpublished) and may influence
germ cell apoptosis by increasing FasL expression in Ser-
toli cells. Identification of the mechanisms involved in
germ cell-specific apoptosis after IR may lead to the devel-
opment of therapies aimed at interrupting specific path-
ways in order to prevent the IR-induced loss of
spermatogenesis.
Autoimmune orchitis
Autoimmune orchitis can occur spontaneously in dogs
[83] and mink [84] and after vasectomy in rabbits [85]
and guinea pigs [86]. Mice that have been thymectomized
within 4 days of birth also develop a similar autoimmune
orichitis [87]. In humans several idiopathic diseases of the
testis have been described that are similar to autoimmune
Following ischemia/reperfusion of the testis IL-1β expression is increased Figure 1
Following ischemia/reperfusion of the testis IL-1β expression is increased. Corresponding with the increase in IL-1β is an acti-
vation of JNK localized to endothelial cells in the testis. Two downstream transcription factors of JNK, ATF-2 and c-jun are 
also activated and are known to form a heterodimer and upregulate E-selectin expression. E-selectin expressed on the surface 
of endothelial cells aids in the recruitment of neutrophils to the testis. Once neutrophils are bound to endothelial cells they can 
transmigrate through the endothelial cells into the interstitium where they are poised to release factors such as reactive oxy-
gen species or other cytokines. The source of IL-1β production after ischemia/reperfusion of the testis is currently unkown; 
however, Sertoli cells, Leydig cells, and interstitial macrophages are candidates.Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/9
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orchitis and are associated with male infertility [23]. Ani-
mals injected with homologous testis antigen also
develop autoimmune orchitis [88]. This animal model
system is known as experimental autoimmune orchitis
(EAO) and is widely used to study this disease.
A role for proinflammatory cytokines in EAO has been
described by Yule and Tung [24], who demonstrated that
injection of a TNF neutralizing antibody abrogated the
effects of EAO. By generating T-lymphocyte clones from
mice with EAO and injecting them into normal mice Yule
and Tung [24] demonstrated the T-lymphocyte clones
induced the testicular autoimmune disease. The T-lym-
phocytes responsible for the transfer of EAO were found
to be of the CD4+ subset and have a cytokine secretion
profile of TNFα, IL-2, and IFNγ. To determine if TNFα had
a role in the development of EAO orchitogenic T-lym-
phocytes were injected into recipient mice along with an
anti-TNFα neutralizing antibody. Results from these
experiments demonstrated that when TNFα was neutral-
ized in vivo, orchitis elicited by an orchitogenic T-lym-
phocyte clone was significantly attenuated suggesting an
important role for TNFα in EAO [24].
Recent studies by Suescun et al [25] provide further evi-
dence for the involvement of TNFα in EAO. Rats with EAO
exhibited a significant increase in the number of TNFα-
positive testicular macrophages. Testicular macrophages
isolated from animals with EAO and cultured secreted
increased amounts of TNFα in the media compared to
macrophage isolated from control animals [25]. An
increase in the number of TNFR1 positive germ cells dur-
ing EAO was also noted suggesting a possible role for
TNFα in germ cell apoptosis during EAO. Suescun et al
[25] postulate that TNFα is probably involved in the pro-
gression of EAO because of its ability to increase endothe-
lial cell permeability, to facilitate monocyte extravasation
in the testis, and to activate T cells and macrophages
through both autocrine and paracrine mechanisms. In
biopsies of human testicular pathologies involving
inflammation an increase in the number of macrophages
and in TNFα expression by testicular macrophages has
also been observed adding further evidence for the
involvement of TNFα in testicular inflammation [89].
Conclusions
TNFα and IL-1 are produced in the testis under normal
physiological conditions and play an important role in
maintaining testicular function. Certain pathologic condi-
tions, for example testicular torsion and autoimmune
orchitis, however cause an increase in the expression of
proinflammatory cytokines. This increase in expression
shifts the balance in favor of inflammatory and immune
responses. Once immune cells are either recruited to the
testis (neutrophils, lymphocytes) or activated in the testis
(macrophages) germ cell apoptosis is observed and sper-
matogenesis is disrupted. By identifying the cells upon
which the proinflammatory cytokines react and by
identifying intracellular signaling cascades activated dur-
ing pathologic conditions of the testis targets for specific
therapies may be uncovered that will aid in maintaining
testicular function.
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